CuraGen Corporation's majority-owned subsidiary 454 Life Sciences has announced that research on small RNAs, conducted by Cold Spring Harbor Laboratory, has revealed the dual role of the ARGONAUTE 4 ...

'This hybrid sequencing strategy has the potential for being the first in years to have a major impact on the sequencing community,' the authors write. Indeed, they estimate the hybrid approach can ...

Roche and CuraGen have announced that they have signed a definitive agreement under which Roche will acquire 100% of 454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation, active in ...